Declared bankruptcy in June 2023
LCI - Lannett Company, Inc.
NYSE
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Trevose,
United States
Type: Equity
LCI price evolution
LCI
| (in millions $) | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $55.85 | $77.92 | ||
| Short term investments | ||||
| Net receivables | $80.34 | $54.92 | ||
| Inventory | $94.78 | $94.12 | ||
| Total current assets | $250.53 | $264.66 | ||
| Long term investments | ||||
| Property, plant & equipment | $125.75 | $134.55 | ||
| Goodwill & intangible assets | $29.64 | $30 | ||
| Total noncurrent assets | $187.83 | $202.64 | ||
| Total investments | ||||
| Total assets | $438.36 | $467.3 | ||
| Current liabilities | ||||
| Accounts payable | $33.16 | $53.41 | ||
| Deferred revenue | ||||
| Short long term debt | $2.07 | $2.07 | ||
| Total current liabilities | $112.22 | $110.14 | ||
| Long term debt | $623.86 | $629.07 | ||
| Total noncurrent liabilities | $638.42 | $634.71 | ||
| Total debt | $635.37 | $631.14 | ||
| Total liabilities | $750.63 | $744.86 | ||
| Shareholders' equity | ||||
| Retained earnings | -$660.71 | -$624.4 | ||
| Other shareholder equity | -$0.37 | -$0.4 | ||
| Total shareholder equity | -$312.27 | -$277.56 | ||
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $87.85 | $93.29 | $144.33 | $140.25 |
| Short term investments | ||||
| Net receivables | $56.24 | $98.83 | $125.69 | $164.75 |
| Inventory | $95.16 | $109.55 | $142.87 | $143.97 |
| Total current assets | $290.12 | $353.56 | $443.21 | $472.25 |
| Long term investments | ||||
| Property, plant & equipment | $142.82 | $177.23 | $188.86 | $186.67 |
| Goodwill & intangible assets | $32.18 | $137.84 | $374.74 | $411.23 |
| Total noncurrent assets | $194.32 | $330.17 | $693.35 | $715.16 |
| Total investments | ||||
| Total assets | $484.44 | $683.74 | $1136.56 | $1187.41 |
| Current liabilities | ||||
| Accounts payable | $56.98 | $62.39 | $91.57 | $75.88 |
| Deferred revenue | ||||
| Short long term debt | $2.06 | $2.04 | $89.29 | $66.84 |
| Total current liabilities | $104.94 | $90.47 | $214.87 | $176.62 |
| Long term debt | $624.94 | $601.73 | $602.78 | $662.2 |
| Total noncurrent liabilities | $630.56 | $620.74 | $618.79 | $676.75 |
| Total debt | $627.01 | $603.77 | $692.07 | $729.05 |
| Total liabilities | $735.5 | $711.21 | $833.66 | $853.37 |
| Shareholders' equity | ||||
| Retained earnings | -$596.39 | -$364.77 | -$1.29 | $32.08 |
| Other shareholder equity | -$0.41 | -$0.55 | -$0.63 | -$0.61 |
| Total shareholder equity | -$251.06 | -$27.47 | $302.9 | $334.04 |
| (in millions $) | 1 May 2023 | 31 Dec 2022 | 30 Oct 2022 | 30 Jul 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $80.89 | |||
| Cost of revenue | $66.62 | |||
| Gross Profit | $14.28 | |||
| Operating activities | ||||
| Research & development | $4.93 | |||
| Selling, general & administrative | $18.32 | |||
| Total operating expenses | $29.05 | |||
| Operating income | -$14.77 | |||
| Income from continuing operations | ||||
| EBIT | -$21.09 | |||
| Income tax expense | $0.03 | |||
| Interest expense | $15.18 | |||
| Net income | ||||
| Net income | -$36.31 | |||
| Income (for common shares) | -$36.31 | |||
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $340.58 | $478.78 | $545.74 | $655.41 |
| Cost of revenue | $307.41 | $403.19 | $380.52 | $411.8 |
| Gross Profit | $33.17 | $75.59 | $165.22 | $243.61 |
| Operating activities | ||||
| Research & development | $22.36 | $24.17 | $29.98 | $38.81 |
| Selling, general & administrative | $81.02 | $68.08 | $79.47 | $87.65 |
| Total operating expenses | $209.44 | $312.84 | $145.66 | $505.93 |
| Operating income | -$176.27 | -$237.25 | $19.56 | -$262.32 |
| Income from continuing operations | ||||
| EBIT | -$175.94 | -$249.02 | $18.22 | -$261.62 |
| Income tax expense | -$2.3 | $60.63 | -$15.26 | -$74.14 |
| Interest expense | $57.98 | $53.83 | $66.84 | $84.62 |
| Net income | ||||
| Net income | -$231.62 | -$363.48 | -$33.37 | -$272.11 |
| Income (for common shares) | -$231.62 | -$363.48 | -$33.37 | -$272.11 |
| (in millions $) | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Net income | -$36.31 | -$28.02 | -$93.3 | -$34.9 |
| Operating activities | ||||
| Depreciation | $6.29 | $6.21 | $7.61 | $7.79 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.53 | $1.58 | $1.38 | $1.7 |
| Total cash flows from operations | -$19.22 | -$11.31 | -$19.01 | -$1.96 |
| Investing activities | ||||
| Capital expenditures | -$1.91 | $1.43 | $0.85 | $9.38 |
| Investments | ||||
| Total cash flows from investing | -$2.91 | $1.43 | $0.6 | $9.38 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | -$0.07 | $0.04 | $0.06 |
| Net borrowings | ||||
| Total cash flows from financing | $0.03 | -$0.07 | $0.04 | $0.06 |
| Effect of exchange rate | $0.03 | $0.01 | $0.12 | -$0.01 |
| Change in cash and equivalents | -$22.07 | -$9.94 | -$18.25 | $7.47 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$231.62 | -$363.48 | -$33.37 | -$272.11 |
| Operating activities | ||||
| Depreciation | $34.27 | $47.82 | $56.31 | $55.59 |
| Business acquisitions & disposals | -$0.25 | |||
| Stock-based compensation | $8.41 | $9.04 | $10.22 | $9.03 |
| Total cash flows from operations | -$7.13 | $60.85 | $116.01 | $176.31 |
| Investing activities | ||||
| Capital expenditures | $3.83 | -$10.3 | -$10.95 | -$9.89 |
| Investments | $5.6 | |||
| Total cash flows from investing | $2.08 | -$14.8 | -$40 | -$7.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.52 | -$0.38 | -$0.91 | $0.59 |
| Net borrowings | -$91.79 | -$63.94 | -$127.84 | |
| Total cash flows from financing | -$0.52 | -$92.17 | -$71.92 | -$127.26 |
| Effect of exchange rate | $0.14 | $0.08 | -$0.01 | -$0.1 |
| Change in cash and equivalents | -$5.43 | -$46.04 | $4.08 | $41.66 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -2.93 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |